Fischer off World Bank contenders list

Bank of Israel Governor Stanley Fischer is reportedly off the list of candidates to replace Paul Wolfowitz as president of the World Bank.

By JERUSALEM POST BUSINESS STAFF
May 28, 2007 07:22

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Bank of Israel Governor Stanley Fischer is reportedly off the list of candidates to replace Paul Wolfowitz as president of the World Bank. Fischer, a former vice president of development economics and chief economist at the World Bank, had been mentioned as a possible successor to Wolfowitz, who resigned earlier this month amid a scandal involving a promotion for his girlfriend. Current lead contenders for the position reportedly are US Trade Representative Robert Zoellick and Deputy Secretary of the Treasury, Robert Kimmitt.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS